A 0.50 mg dose = 50 units
CysLT1 Receptor Antagonist Alleviates Pathogenesis of Collagen-Induced Arthritis Mouse Model
The trial began in March 2021 and concluded in January 2024, comprising a two-week screening period, a 12-week run-in period, and a 56-week treatment period, followed by a 26-week follow-up period
With clear pricing, ongoing support, and real-world success stories, LifeRx offers you the chance to make meaningful progress toward your goals
Before opening: Store in a refrigerator (2 C8 C)
Understanding Vitamin B12 B12 plays a crucial role in various body functions, including brain function, nerve function, and red blood cell production